Allergan Launches National Campaign to Raise Awareness of the Toll Glaucoma Takes on Everyday Living

By Allergan Nov 2019

Allergan plc announced a national education campaign called My Glaucoma.

Allergan Expands REFRESH® Portfolio with New Refresh® RELIEVA™ Lubricant Eye Drop Product Line

By Allergan Nov 2019

Allergan plc announced the launch of three new over-the-counter (OTC) REFRESH® RELIEVA™ products.

Allergan and Molecular Partners Present Late-breaking Data from Phase 3 Studies of Investigational Abicipar Pegol in Neovascular Wet Age-related Macular Degeneration

By Allergan Nov 2019

Allergan plc and Molecular Partners, a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies, announced two-year data from the CEDAR and SEQUOIA clinical studies of investigational Abicipar in patients with neovascular (wet) age-related macular degeneration (nAMD).

Macular Degeneration & Glaucoma Late Stage Data

By Allergan Nov 2019

Allergan plc will present new data from investigational Abicipar and Bimatoprost Sustained Release (SR) at the Annual Meeting of the American Academy of Ophthalmology (AAO) to be held in San Francisco, California.

Women In Optometry First Leadership Summit

By WO Sep 2019

Women In Optometry releases full coverage of its inaugural leadership summit.


Loading...